medifoxamine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryMedifoxamine is a monoamine reuptake inhibiting antidepressant drug. We have investigated its pharmacokinetics in normal…
Abstract The strategy in the choice of antipsychotic agent must take into account the hepatic tolerance according to non…
The strategy in the choice of antipsychotic agent must take into account the hepatic tolerance according to non-negligible…
In order to assess the internal structure of MADRS, a principal component analysis was performed in a group of 137 patients…
The serotonin (5-HT) is implicated in many centrally-regulated functions and has shown to be involved in affective disorders…
Medifoxamine (Clédial TM), a non tricyclic non MAOI antidepressant drug with a dopaminergic and serotoninergic mechanism of…
Medifoxamine is a new monoamine re-uptake inhibiting antidepressant drug. Twelve volunteers received 100 mg by i.v. infusion over…
Medifoxamine is a new antidepressant drug which is in clinical use in France and is undergoing clinical investigation elsewhere…
Ten volunteers received single oral doses of medifoxamine 50 and 100 mg, atropine 1 mg, amitriptyline 50 mg or placebo in random…
Medifoxamine is a new investigational antidepressant drug. Its buccal absorption at pH 5–9, which can be considered as an in‐vivo…